Last Updated:
Completed
Create account to add to watchlist!

Sema4 Holdings Corp. - SMFR

  • Commons

    $3.46

    +7.97%

    SMFR Vol: 863.3K

  • Warrants

    $0.69

    +2.24%

    SMFRW Vol: 14.6K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 1.2G
Average Volume: 1.5M
52W Range: $4.46 - $12.65
Weekly %: -0.43%
Monthly %: -32.22%
Inst Owners: 99

Info

Description: Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions for governmental organizations, K-12 schools, higher education institutions, large businesses, and healthcare providers, as well as residents in Connecticut. Sema4 Holdings Corp. is headquartered in Stamford, Connecticut.

Industry: Health Information Services

Website: https://www.sema4.com

🎯Price Targets

Rating

Analyst Firm

Price Target

Goldman Sachs

11/19/21

Buy - $12.0

BTIG

10/08/21

Buy - $12.0

Cowen & Co.

9/30/21

Outperform - $13.0

Jefferies

9/24/21

Buy - $13.0

πŸ“°News and PRs

πŸ•΅Stocktwit Mentions

EarningsInsider posted at 2022-01-20T14:50:54Z

Jefferies Financial Group Sets Sema4 FY2024 Earnings Estimates at ($0.39) EPS. https://www.marketbeat.com/x/1164290 $SMFR

aascheib posted at 2022-01-20T14:49:43Z

$SMFR FOMO ?

cctranscripts posted at 2022-01-20T14:39:57Z

Stephen A. Schwarzman just provided an update on activist position in Sema4 Holdings Corp. https://www.conferencecalltranscripts.com/summary/?id=10336266 $SMFR

ChartMill posted at 2022-01-20T13:41:00Z

$SMFR has a better Quick Ratio than the average industry Quick Ratio of 2.32 https://www.chartmill.com/stock/quote/SMFR/fundamental-analysis?key=3d37ea31-d80c-4680-a402-1ad31a189cb4&utm_source=stocktwits&utm_medium=FA&utm_content=SMFR&utm_campaign=social_tracking

Newsfilter posted at 2022-01-20T11:12:28Z

$SMFR Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/a19ab40ede2bb06ad6f13686e807d0bd

ChartMill posted at 2022-01-20T06:42:00Z

$SMFR: The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years. https://www.chartmill.com/stock/analyzer/stock/SMFR?view=fundamental-analysis&key=3d37ea31-d80c-4680-a402-1ad31a189cb4&utm_source=stocktwits&utm_medium=FA&utm_content=SMFR&utm_campaign=social_tracking

cctranscripts posted at 2022-01-20T06:36:57Z

SEMA4 HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &amp, Foti, LLC Investigates Sema4 Holdings Corp. - SMFR https://conferencecalltranscripts.com/summary/?id=363261&pr=true $SMFR

fla posted at 2022-01-20T06:30:49Z

$SMFR [15s. delayed]: Issued Press Release on January 20, 01:25:00: SEMA4 HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISI https://s.flashalert.me/W9MF7

cctranscripts posted at 2022-01-20T00:41:27Z

Sema4 Holdings Corp.'s Secretary and General Counsel just picked up 275,000 shares https://www.conferencecalltranscripts.com/summary/?id=10334202 $SMFR

Quantisnow posted at 2022-01-20T00:38:54Z

$SMFR πŸ“œ SEC Form 4: Clark Daniel Emmett exercised 275,000 shares at a strike of $0.15, increasing direct ownership by 4,303% to 281,391 units https://quantisnow.com/insight/2274468?s=s 45 seconds delayed.

Newsfilter posted at 2022-01-20T00:38:06Z

$SMFR $41,250.00 of shares acquired by Clark Daniel Emmett (Secretary and General Counsel), reported in a new form 4 filed with the SEC https://newsfilter.io/a/9cb8c75f43161cf15d2dd236c39e8de6

cctranscripts posted at 2022-01-19T21:33:26Z

KEITH A. MEISTER just provided an update on activist position in Sema4 Holdings Corp. https://www.conferencecalltranscripts.com/summary/?id=10333143 $SMFR

Quantisnow posted at 2022-01-19T21:28:50Z

$SMFR πŸ“œ SEC Form SC 13D/A filed by Sema4 Holdings Corp. (Amendment) https://quantisnow.com/insight/2273538?s=s 45 seconds delayed.

Newsfilter posted at 2022-01-19T21:28:06Z

$SMFR Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC https://newsfilter.io/a/f2ee253bf10fdbfe140bf8320eaa6308

Thos01 posted at 2022-01-19T21:00:05Z

$SMFR really happy with this investment so far

brucy1000 posted at 2022-01-19T20:43:04Z

$SMFR I wrote before high 2s might be safe, changing my mind to high 1s.

InvestoTheClown posted at 2022-01-19T20:40:40Z

$SMFR if you told me last year this will be trading in the low 3s I would have called you a conspiracy theorist. Here we are... turd. I have to vomit

Magic_Investor posted at 2022-01-19T19:17:24Z

$OPK given our large stake in $SMFR Opko shareholders should probably pay attention to their earnings calls and be in touch with their IR. Opko has a very large position which will effect our bottom line if and when Sema4 is profitable. My $0.02

Aluicious1 posted at 2022-01-19T17:10:03Z

$SMFR lol mannnnnnnn, and I covered at 11! Haven't checked this in months but boy, should have let that one ride.

tickeron posted at 2022-01-19T17:07:17Z

What do you think of this? $SMFR enters a Downtrend because Momentum Indicator dropped below the 0 level on January 11, 2022. View odds for this and other indicators: https://srnk.us/go/3338073

mulder35 posted at 2022-01-19T16:55:18Z

$SMFR THANKS BRANDON FOR ALL YOU'RE DOING FOR THE MARKETS!!! YOU'RE THE BEST.... wow

humour posted at 2022-01-19T15:31:39Z

$SMFR $OPK two sh*tcos made a deal 🀝 lol Sema4 hasn't figured out how to scale their business first. Very poor move from sema4 side

mulder35 posted at 2022-01-19T15:22:33Z

$SMFR 212 Million revenue for thee year and want to sell at 3.30??? 3.30!!!! Gtfo I'm buying

ChartMill posted at 2022-01-19T15:20:00Z

$SMFR has a Current Ratio of 7.55, so it is financially healthy and has no problem in meeting its obligations. https://www.chartmill.com/stock/analyzer/stock/SMFR?view=fundamental-analysis&key=3d37ea31-d80c-4680-a402-1ad31a189cb4&utm_source=stocktwits&utm_medium=FA&utm_content=SMFR&utm_campaign=social_tracking

badger1200 posted at 2022-01-19T15:03:16Z

$SMFR sold one of the Crown Jewels to a company whose stock has tanked from 27 What have we got ?

Magic_Investor posted at 2022-01-19T14:51:14Z

$SMFR how low is this going?

shortablestocks posted at 2022-01-19T14:08:30Z

$SMFR is short sale restricted for 2022-01-19. https://www.shortablestocks.com/?SMFR

Wolverine2017 posted at 2022-01-19T13:50:07Z

$SMFR green is your name? It’s nice to meet you.

ChartMill posted at 2022-01-19T08:20:00Z

$SMFR was analyzed by 10 analysts. The buy consensus is at 86%. So analysts seem to be very confident about $SMFR. https://www.chartmill.com/stock/quote/SMFR/analyst-ratings?utm_source=stocktwits&utm_medium=ANALYST&utm_content=SMFR&utm_campaign=social_tracking

opko_fan posted at 2022-01-19T00:45:56Z

$OPK $SMFR I think this is a tremendous deal for both companies as the synergies will allow each of their businesses to take off. GeneDX has been growing at a good rate, has a pretty good profit margin, and has an invaluable database of 300,000 exomes from which the combined firm will benfit. Sema4 has also been growing at a good rate, has its own invaluable database, but could benefit from a partner that does well in areas in which it is not yet that active and/or doesn't have the same level of expertise. Added to that are the close relationships which will be and/or already have been developed with new part owners Pfizer and Opko. :) I think the combined firm will become the leader in genetic testing and genome/exome data. Bought my first shares of SMFR today and they won't be my last. Her's the news release about the 300,000 person GeneDX database from last September: https://www.prnewswire.com/news-releases/genedx-announces-the-sequencing-of-more-than-300-000-clinical-patient-exomes-301381900.html Here's my belief about the enormous value of data: https://stocktwits.com/opko_fan/message/382631247

Holder Stats

1 0
% of Shares Held by All Insider 45.87%
% of Shares Held by Institutions 46.11%
% of Float Held by Institutions 85.18%
Number of Institutions Holding Shares 99

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Vanguard Extended Market Index Fund 1630032 2021-09-29 12371942 0.6799999999999999
Price (T.Rowe) Health Sciences Fund 1419923 2021-09-29 10777215 0.59
Morgan Stanley Inst Fund Inc-Inception Port 1335805 2021-09-29 10138759 0.5500000000000002
Vanguard Total Stock Market Index Fund 1248015 2021-09-29 9472433 0.52
ACAP Strategic Fund 1067890 2021-09-29 8105285 0.44
Price (T.Rowe) New Horizons Fund 1023292 2021-09-29 7766786 0.42
Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I 643170 2021-08-30 6110115 0.27
Fidelity Extended Market Index Fund 623295 2021-10-30 5029990 0.26
EQ Advisors Trust-EQ/Morgan Stanley Small Cap Growth Port 411938 2021-09-29 3126609 0.16999999999999998
Advantage Advisers Xanthus Fund, LLC 335323 2021-09-29 2545101 0.13999999999999999

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-12-03 Perceptive Advisors LLC 2,500,000 $18,980,000 0.3% 0 1.036%
2021-11-18 Bank of New York Mellon Corp 49,330 $370,000 0.0% 0 0.020%
2021-11-16 Schonfeld Strategic Advisors LLC 126,700 $960,000 0.0% 0 0.053%
2021-11-16 Cetera Advisor Networks LLC 79,200 $600,000 0.0% 0 0.033%
2021-11-16 Adalta Capital Management LLC 34,000 $260,000 0.1% 0 0.014%
2021-11-16 UBS Group AG 25,250 $190,000 0.0% 0 0.011%
2021-11-16 Wellington Management Group LLP 157,636 $1,200,000 0.0% 0 0.066%
2021-11-16 Moore Capital Management LP 350,000 $2,660,000 0.0% 0 0.146%
2021-11-16 Bleichroeder LP 100,000 $760,000 0.1% 0 0.042%
2021-11-16 Casdin Capital LLC 5,000,000 $37,950,000 0.9% 0 2.082%
2021-11-15 Third Point LLC 2,795,000 $21,210,000 0.1% 0 1.164%
2021-11-15 Deerfield Management Company L.P. Series C 13,848,488 $105,110,000 2.1% 0 5.766%
2021-11-15 Cubist Systematic Strategies LLC 174,200 $1,320,000 0.0% 0 0.073%
2021-11-15 RTW Investments LP 400,000 $2,940,000 0.0% 0 0.167%
2021-11-15 JS Capital Management LLC 1,000,000 $7,590,000 0.4% 0 0.416%
2021-11-15 Tudor Investment Corp Et Al 13,975 $110,000 0.0% 0 0.006%
2021-11-15 Marshall Wace LLP 2,125,550 $16,129,999 0.1% +4.3% 0.885%
2021-11-15 683 Capital Management LLC 172,316 $1,310,000 0.1% 0 0.072%
2021-11-15 Royal Bank of Canada 4,700 $36,000 0.0% 0 0.002%
2021-11-15 Capstone Investment Advisors LLC 23,291 $180,000 0.0% 0 0.010%
2021-11-15 Viking Global Investors LP 3,000,000 $22,770,000 0.1% 0 1.249%
2021-11-15 Morgan Stanley 3,647,984 $27,690,000 0.0% 0 1.519%
2021-11-15 Penserra Capital Management LLC 24,929 $190,000 0.0% 0 0.010%
2021-11-15 HighTower Advisors LLC 104,593 $800,000 0.0% 0 0.044%
2021-11-12 SB Management Ltd 9,021,524 $68,470,000 7.0% 0 3.756%
2021-11-12 Gagnon Securities LLC 696,043 $5,280,000 0.8% 0 0.290%
2021-11-12 Rockefeller Capital Management L.P. 25,890 $200,000 0.0% 0 0.011%
2021-11-12 Geode Capital Management LLC 1,196,879 $9,080,000 0.0% 0 0.498%
2021-11-12 Magnetar Financial LLC 32,521 $250,000 0.0% 0 0.014%
2021-11-10 Goldman Sachs Group Inc. 15,150 $120,000 0.0% 0 0.006%
2021-11-10 Oxbow Advisors LLC 30,500 $230,000 0.0% 0 0.013%
2021-11-10 Citigroup Inc. 10,448 $79,000 0.0% 0 0.004%
2021-11-09 BlackRock Inc. 1,669,781 $12,670,000 0.0% 0 0.695%
2021-11-09 TD Asset Management Inc. 106,135 $810,000 0.0% 0 0.044%
2021-11-03 Clearwater Capital Advisors LLC 12,224 $93,000 0.0% 0 0.005%
2021-11-02 Victory Capital Management Inc. 11,529 $88,000 0.0% 0 0.005%
2021-11-01 SG Americas Securities LLC 26,472 $200,000 0.0% 0 0.011%
2021-10-25 Zweig DiMenna Associates LLC 301,492 $2,290,000 0.2% 0 0.126%
2021-10-18 Samson Rock Capital LLP 20,034 $150,000 0.1% 0 0.008%
2021-10-13 Deltec Asset Management LLC 15,000 $110,000 0.0% 0 0.006%
2021-08-25 Marshall Wace LLP 2,038,507 $28,560,000 0.1% 0 0.849%
2021-08-25 Marshall Wace North America L.P. 129,506 $1,810,000 0.0% 0 0.054%
2021-08-16 Marshall Wace LLP 2,038,507 $28,560,000 0.1% 0 3.683%

SEC Filings

Form Type Form Description Filing Date Document Link
DEFA14A DEFA14A 2022-01-18 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000016/defa14a-1182022.htm
DEFA14A DEFA14A 2022-01-18 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000014/defa14a-1182022xacqannounc.htm
424B3 424B3 2022-01-18 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000012/smfr-424b3supplementno6sx1.htm
8-K 8-K 2022-01-18 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000010/smfr-20220114.htm
424B3 424B3 2022-01-10 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000008/smfr-424b3supplementno5sx1.htm
8-K 8-K 2022-01-10 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000006/smfr-20220110.htm
424B3 424B3 2022-01-10 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000004/smfr-424b3supplementno4sx1.htm
8-K 8-K 2022-01-10 https://www.sec.gov/Archives/edgar/data/1818331/000181833122000002/smfr-20220110.htm
SC 13G/A SC 13G/A 2022-01-07 https://www.sec.gov/Archives/edgar/data/1818331/000110465922002139/tm222170d15_sc13ga.htm
8-K 8-K 2021-12-16 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000017/smfr-20211215.htm
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069335/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069334/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069333/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069332/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069330/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069329/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069328/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-13 https://www.sec.gov/Archives/edgar/data/1818331/000120919121069327/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067991/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067990/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067989/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067988/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067987/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067986/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067985/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-03 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067984/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-12-01 https://www.sec.gov/Archives/edgar/data/1818331/000120919121067376/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-15 https://www.sec.gov/Archives/edgar/data/1818331/000120919121064519/xslF345X03/doc4.xml
424B3 424B3 2021-11-15 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000014/smfr-424b3suppno3sx1.htm
10-Q 10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000012/cmlf-20210930.htm
8-K 8-K 2021-11-15 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000010/smfr-20211115.htm
4 FORM 4 SUBMISSION 2021-11-10 https://www.sec.gov/Archives/edgar/data/1818331/000120919121063952/xslF345X03/doc4.xml
4/A FORM 4/A SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062559/xslF345X03/doc4a.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062556/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062555/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062554/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062552/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062551/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062549/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062548/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-11-02 https://www.sec.gov/Archives/edgar/data/1818331/000120919121062546/xslF345X03/doc4.xml
S-8 S-8 2021-10-25 https://www.sec.gov/Archives/edgar/data/1818331/000162828021020443/s-8filingx102521.htm
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061032/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061031/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061029/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061028/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061026/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061025/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061023/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-19 https://www.sec.gov/Archives/edgar/data/1818331/000120919121061021/xslF345X03/doc4.xml
424B3 424B3 2021-10-15 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000006/smfr-424b3supplementno2sx1.htm
424B3 424B3 2021-10-15 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000004/smfr-424b3supplementno2sx1.htm
8-K 8-K 2021-10-14 https://www.sec.gov/Archives/edgar/data/1818331/000181833121000002/smfr-20211008.htm
SC 13D SCHEDULE 13D 2021-10-13 https://www.sec.gov/Archives/edgar/data/1818331/000121390021052595/ea148771-13dicahn_sema4.htm
3 FORM 3 SUBMISSION 2021-10-07 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059995/xslF345X02/doc3.xml
4 FORM 4 SUBMISSION 2021-10-06 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059876/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059760/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059759/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059758/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059757/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059756/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059755/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059754/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-10-05 https://www.sec.gov/Archives/edgar/data/1818331/000120919121059753/xslF345X03/doc4.xml
S-8 S-8 2021-09-27 https://www.sec.gov/Archives/edgar/data/1818331/000162828021019193/s-8.htm
SC 13D SC 13D 2021-08-30 https://www.sec.gov/Archives/edgar/data/1818331/000119312521260701/d58365dsc13d.htm
3 FORM 3 SUBMISSION 2021-08-30 https://www.sec.gov/Archives/edgar/data/1818331/000089924321034518/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-08-30 https://www.sec.gov/Archives/edgar/data/1818331/000089924321034516/xslF345X02/doc3.xml
424B3 424B3 2021-08-17 https://www.sec.gov/Archives/edgar/data/1818331/000162828021017158/s-1prospectussupplementno1.htm
8-K/A 8-K/A 2021-08-16 https://www.sec.gov/Archives/edgar/data/1818331/000162828021017147/smfr-20210722.htm
8-K 8-K 2021-08-16 https://www.sec.gov/Archives/edgar/data/1818331/000162828021017120/smfr-20210813.htm
EFFECT 2021-08-12 https://www.sec.gov/Archives/edgar/data/1818331/999999999521003194/xslEFFECTX01/primary_doc.xml
424B3 424B3 2021-08-12 https://www.sec.gov/Archives/edgar/data/1818331/000162828021016856/sema4424b.htm
CORRESP 2021-08-10 https://www.sec.gov/Archives/edgar/data/1818331/000162828021016395/filename1.htm
UPLOAD 2021-08-10 https://www.sec.gov/Archives/edgar/data/1818331/000000000021009768/filename1.pdf
S-1 S-1 2021-08-04 https://www.sec.gov/Archives/edgar/data/1818331/000162828021015606/cmlf-20210804.htm
SC 13D SCHEDULE 13D 2021-08-02 https://www.sec.gov/Archives/edgar/data/1818331/000121390021039855/ea145125-13dcmls_sema4.htm
SC 13G 2021-08-02 https://www.sec.gov/Archives/edgar/data/1818331/000119380521001086/e620834_sc13g-sema4.htm
8-K 8-K 2021-07-28 https://www.sec.gov/Archives/edgar/data/1818331/000162828021014760/super8-k.htm
4 2021-07-27 https://www.sec.gov/Archives/edgar/data/1818331/000121390021038789/xslF345X03/ownership.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048253/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048230/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048229/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048228/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048227/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048226/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048225/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2021-07-26 https://www.sec.gov/Archives/edgar/data/1818331/000120919121048224/xslF345X03/doc4.xml
25-NSE 2021-07-23 https://www.sec.gov/Archives/edgar/data/1818331/000135445721000842/xslF25X02/primary_doc.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047802/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047798/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047796/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047775/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047773/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047771/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047770/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047769/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047767/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047765/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047761/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047758/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000120919121047753/xslF345X02/doc3.xml
8-K CURRENT REPORT 2021-07-22 https://www.sec.gov/Archives/edgar/data/1818331/000121390021037979/ea144582-8k_cmlifescien.htm
10-Q QUARTERLY REPORT 2021-07-21 https://www.sec.gov/Archives/edgar/data/1818331/000121390021037929/f10q0621_cmlifesciences.htm
8-K CURRENT REPORT 2021-07-19 https://www.sec.gov/Archives/edgar/data/1818331/000121390021037524/ea144454-8k_cmlife.htm
DEFA14A CURRENT REPORT 2021-07-19 https://www.sec.gov/Archives/edgar/data/1818331/000121390021037525/ea144454-8k_cmlife.htm
SC 13G SC 13G 2021-07-09 https://www.sec.gov/Archives/edgar/data/1818331/000110465921090527/tm2121771d1_sc13g.htm
UPLOAD 2021-07-02 https://www.sec.gov/Archives/edgar/data/1818331/000000000021008252/filename1.pdf
CORRESP 2021-07-02 https://www.sec.gov/Archives/edgar/data/1818331/000162828021013410/filename1.htm
DEFM14A DEFM14A 2021-07-02 https://www.sec.gov/Archives/edgar/data/1818331/000162828021013404/sema4proxy.htm
UPLOAD 2021-07-01 https://www.sec.gov/Archives/edgar/data/1818331/000000000021008095/filename1.pdf
CORRESP 2021-06-28 https://www.sec.gov/Archives/edgar/data/1818331/000162828021013049/filename1.htm
PRER14A PRER14A 2021-06-28 https://www.sec.gov/Archives/edgar/data/1818331/000162828021013047/sema4proxy.htm
UPLOAD 2021-06-25 https://www.sec.gov/Archives/edgar/data/1818331/000000000021007820/filename1.pdf
DEFA14A SOLICITING MATERIAL PURSUANT TO 240.14A-12 2021-06-11 https://www.sec.gov/Archives/edgar/data/1818331/000121390021031957/ea142572-defa14a_cmlife.htm
DEFA14A SOLICITING MATERIAL PURSUANT TO 240.14A-12 2021-06-11 https://www.sec.gov/Archives/edgar/data/1818331/000121390021031956/ea142571-defa14a_cmlife.htm
CORRESP 2021-06-10 https://www.sec.gov/Archives/edgar/data/1818331/000162828021012041/filename1.htm
PRER14A PRER14A 2021-06-10 https://www.sec.gov/Archives/edgar/data/1818331/000162828021012033/sema4proxy.htm
UPLOAD 2021-06-02 https://www.sec.gov/Archives/edgar/data/1818331/000000000021006860/filename1.pdf
10-Q QUARTERLY REPORT 2021-05-24 https://www.sec.gov/Archives/edgar/data/1818331/000121390021028608/f10q0321_cmlifesciences.htm
NT 10-Q NOTIFICATION OF LATE FILING 2021-05-18 https://www.sec.gov/Archives/edgar/data/1818331/000121390021027533/ea141240-nt10q_cmlife.htm
425 FORM 425 2021-05-07 https://www.sec.gov/Archives/edgar/data/1818331/000121390021024941/ea140461-425_cmlifescien.htm
PREM14A PREM14A 2021-05-06 https://www.sec.gov/Archives/edgar/data/1818331/000162828021009360/sema4proxy.htm
10-K/A AMENDMENT NO. 1 TO FORM 10-K 2021-05-05 https://www.sec.gov/Archives/edgar/data/1818331/000121390021024584/f10k2020a1_cmlifesciences.htm
425 CURRENT REPORT 2021-05-05 https://www.sec.gov/Archives/edgar/data/1818331/000121390021024581/ea140287-8k_cmlife.htm
8-K CURRENT REPORT 2021-05-05 https://www.sec.gov/Archives/edgar/data/1818331/000121390021024579/ea140287-8k_cmlife.htm
10-K ANNUAL REPORT 2021-03-30 https://www.sec.gov/Archives/edgar/data/1818331/000121390021018697/f10k2020_cmlifesciences.htm
SC 13G SCHEDULE 13G 2021-02-16 https://www.sec.gov/Archives/edgar/data/1818331/000121390021009631/ea135729-13gcmls_cmlife.htm
DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIAL 2021-02-12 https://www.sec.gov/Archives/edgar/data/1818331/000121390021008641/ea135228-defa14a_cmlife.htm
SC 13G SC 13G 2021-02-12 https://www.sec.gov/Archives/edgar/data/1818331/000110465921020885/tm215944d28_sc13g.htm
8-K CURRENT REPORT 2021-02-11 https://www.sec.gov/Archives/edgar/data/1818331/000121390021008253/ea135116-8k_cmlifesciences.htm
DEFA14A CURRENT REPORT 2021-02-11 https://www.sec.gov/Archives/edgar/data/1818331/000121390021008254/ea135116-8k_cmlifesciences.htm
DEFA14A CURRENT REPORT 2021-02-10 https://www.sec.gov/Archives/edgar/data/1818331/000121390021007929/ea135108-8k_cmlifesciences.htm
8-K CURRENT REPORT 2021-02-10 https://www.sec.gov/Archives/edgar/data/1818331/000121390021007928/ea135108-8k_cmlifesciences.htm
SC 13G/A 2021-01-19 https://www.sec.gov/Archives/edgar/data/1818331/000131924421000023/CMLF_SC13GA1.htm
10-Q QUARTERLY REPORT 2020-11-16 https://www.sec.gov/Archives/edgar/data/1818331/000121390020037276/f10q0920_cmlifesciences.htm
8-K CURRENT REPORT 2020-10-23 https://www.sec.gov/Archives/edgar/data/1818331/000121390020033077/ea128856-8k_cmlifescien.htm
SC 13G 2020-09-11 https://www.sec.gov/Archives/edgar/data/1818331/000090514820001017/efc20-714_sc13g.htm
8-K CURRENT REPORT 2020-09-11 https://www.sec.gov/Archives/edgar/data/1818331/000121390020026282/ea126736-8k_cmlifesciences.htm
SC 13G CM LIFE SCIENCES, INC. 2020-09-11 https://www.sec.gov/Archives/edgar/data/1818331/000090266420003294/p20-1685sc13g.htm
SC 13G 2020-09-08 https://www.sec.gov/Archives/edgar/data/1818331/000131924420000121/CMLF_SC13G.htm
8-K CURRENT REPORT 2020-09-04 https://www.sec.gov/Archives/edgar/data/1818331/000121390020025454/ea126481-8k_cmlifescience.htm
424B4 PROSPECTUS 2020-09-03 https://www.sec.gov/Archives/edgar/data/1818331/000121390020025225/f424b40920_cmlife.htm
EFFECT 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/999999999520002331/xslEFFECTX01/primary_doc.xml
S-1MEF REGISTRATION STATEMENT 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024904/ea126324-s1mef_cmlifescience.htm
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024768/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024766/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024764/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024762/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024759/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024757/xslF345X02/ownership.xml
3 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024754/xslF345X02/ownership.xml
CERT 2020-09-01 https://www.sec.gov/Archives/edgar/data/1818331/000135445720000446/8A_Cert_CMLF.pdf
8-A12B FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES 2020-08-31 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024549/ea126225-8a12b_cmlifescience.htm
CORRESP 2020-08-28 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024342/filename1.htm
CORRESP 2020-08-28 https://www.sec.gov/Archives/edgar/data/1818331/000121390020024340/filename1.htm
CORRESP 2020-08-27 https://www.sec.gov/Archives/edgar/data/1818331/000121390020023962/filename1.htm
S-1/A AMENDMENT NO. 2 TO FORM S-1 2020-08-27 https://www.sec.gov/Archives/edgar/data/1818331/000121390020023960/ea126102-s1a2_cmlifesciences.htm
UPLOAD 2020-08-26 https://www.sec.gov/Archives/edgar/data/1818331/000000000020008020/filename1.pdf
CORRESP 2020-08-24 https://www.sec.gov/Archives/edgar/data/1818331/000121390020023385/filename1.htm
S-1/A REGISTRATION STATEMENT 2020-08-24 https://www.sec.gov/Archives/edgar/data/1818331/000121390020023383/fs12020a1_cmlifescience.htm
UPLOAD 2020-08-19 https://www.sec.gov/Archives/edgar/data/1818331/000000000020007639/filename1.pdf
S-1 REGISTRATION STATEMENT 2020-08-14 https://www.sec.gov/Archives/edgar/data/1818331/000121390020022185/fs12020_cmlifesciences.htm
DRS 2020-07-23 https://www.sec.gov/Archives/edgar/data/1818331/000121390020018428/filename1.htm